** Shares of WuXi Biologics (Cayman) Inc 2269.HK drop 7.3% to HK$25.95, on track for the biggest one-day pct fall since April 7
** Stock hits the lowest since June 10, and on course to snap five consecutive sessions of gain
** Top pct loser on Hang Seng Biotech Index .HSHKBIO, which gains 0.5%
** The biologics discovery, development and manufacturing group said key shareholder WuXi Biologics Holdings plans sale of 2.04% stake for HK$2.21 bln ($281.55 mln) in share placement, reducing its stake in the firm to 12.32% from 14.36%
** The key shareholder plans sale of 82.94 mln existing shares at HK$26.60 each, or 5% discount to Friday's close of HK$28 each
** Hong Kong's healthcare index .HSCIH adds 0.3%, while Hang Seng Index .HSI slips 0.4%
** YTD, stock up 51.8% YTD
($1 = 7.8494 Hong Kong dollars)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.